U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula 2C22H27N5O4.4ClH.H2O
Molecular Weight 1014.821
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of LOSOXANTRONE HYDROCHLORIDE

SMILES

O.Cl.Cl.Cl.Cl.OCCNCCNC1=CC=C2N(CCNCCO)N=C3C2=C1C(=O)C4=C3C=CC=C4O.OCCNCCNC5=CC=C6N(CCNCCO)N=C7C6=C5C(=O)C8=C7C=CC=C8O

InChI

InChIKey=CNQCTSLNJJVSAU-UHFFFAOYSA-N
InChI=1S/2C22H27N5O4.4ClH.H2O/c2*28-12-9-23-6-7-25-15-4-5-16-20-19(15)22(31)18-14(2-1-3-17(18)30)21(20)26-27(16)11-8-24-10-13-29;;;;;/h2*1-5,23-25,28-30H,6-13H2;4*1H;1H2

HIDE SMILES / InChI
Losoxantrone is an anthrapyrazole that induces both single and double strand breaks in DNA and is a potent inhibitor of DNA synthesis. The drug is in clinical trials for the treatment of breast cancer and of prostate cancer that is refractory to androgen ablation. Acute toxicity is negligible. Losoxantrone may be less cardiotoxic than doxorubicin. Up to 40% of patients encounter alopecia. 3% of patients develop congestive heart failure. Losoxantrone had been in phase II clinical trial for the treatment of breast and prostate cancer. However, this development was discontinued.

Approval Year

PubMed

PubMed

TitleDatePubMed
A novel 9-aza-anthrapyrazole effective against human prostatic carcinoma xenografts.
2001
Phase I study of the combination of losoxantrone and cyclophosphamide in patients with refractory solid tumours.
2002 Feb 12
Patents

Patents

Sample Use Guides

In Vivo Use Guide
Sources: DOI: 10.1016/0959-8049(93)91029-K
Starting dose of 50 mg/m2 q3 weeks. Dose adjustments could be made anytime after the first dose
Route of Administration: Intravenous
Name Type Language
LOSOXANTRONE HYDROCHLORIDE
USAN  
USAN  
Official Name English
LOSOXANTRONE DIHYDROCHLORIDE HEMIHYDRATE
Common Name English
7-Hydroxy-2-[2-[(2-hydroxyethyl)amino]ethyl]-5-[[2-[(2-hydroxyethyl)amino]ethyl]amino]anthra[1,9-cd]pyrazol-6(2H)-one, dihydrochloride, hemihydrate
Common Name English
LOSOXANTRONE HYDROCHLORIDE [USAN]
Common Name English
DUP-941
Code English
DUP 941
Code English
NSC-357885
Code English
CI-941
Code English
ANTHRA(1,9-CD)PYRAZOL-6(2H)-ONE, 7-HYDROXY-2-(2-((2-HYDROXYETHYL)AMINO)ETHYL)-5-((2-((2-HYDROXYETHYL)AMINO)ETHYL)AMINO)-, DIHYDROCHLORIDE, HYDRATE (2:1)
Common Name English
PD-113785
Code English
Losoxantrone hydrochloride hydrate [WHO-DD]
Common Name English
LOSOXANTRONE HYDROCHLORIDE HYDRATE
WHO-DD  
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C2107
Created by admin on Fri Dec 15 15:59:49 GMT 2023 , Edited by admin on Fri Dec 15 15:59:49 GMT 2023
Code System Code Type Description
USAN
DD-76
Created by admin on Fri Dec 15 15:59:49 GMT 2023 , Edited by admin on Fri Dec 15 15:59:49 GMT 2023
PRIMARY
FDA UNII
W6E275IURX
Created by admin on Fri Dec 15 15:59:49 GMT 2023 , Edited by admin on Fri Dec 15 15:59:49 GMT 2023
PRIMARY
NCI_THESAURUS
C72077
Created by admin on Fri Dec 15 15:59:49 GMT 2023 , Edited by admin on Fri Dec 15 15:59:49 GMT 2023
PRIMARY
ChEMBL
CHEMBL83520
Created by admin on Fri Dec 15 15:59:49 GMT 2023 , Edited by admin on Fri Dec 15 15:59:49 GMT 2023
PRIMARY
PUBCHEM
166541
Created by admin on Fri Dec 15 15:59:49 GMT 2023 , Edited by admin on Fri Dec 15 15:59:49 GMT 2023
PRIMARY
EPA CompTox
DTXSID70157873
Created by admin on Fri Dec 15 15:59:49 GMT 2023 , Edited by admin on Fri Dec 15 15:59:49 GMT 2023
PRIMARY
NSC
357885
Created by admin on Fri Dec 15 15:59:49 GMT 2023 , Edited by admin on Fri Dec 15 15:59:49 GMT 2023
PRIMARY
CAS
132937-89-4
Created by admin on Fri Dec 15 15:59:49 GMT 2023 , Edited by admin on Fri Dec 15 15:59:49 GMT 2023
PRIMARY
EVMPD
SUB02975MIG
Created by admin on Fri Dec 15 15:59:49 GMT 2023 , Edited by admin on Fri Dec 15 15:59:49 GMT 2023
PRIMARY
SMS_ID
100000086173
Created by admin on Fri Dec 15 15:59:49 GMT 2023 , Edited by admin on Fri Dec 15 15:59:49 GMT 2023
PRIMARY